{"id":13543,"date":"2022-06-13T03:05:19","date_gmt":"2022-06-13T01:05:19","guid":{"rendered":"https:\/\/nexxus-iberia.es\/?p=13543"},"modified":"2025-12-11T16:24:40","modified_gmt":"2025-12-11T15:24:40","slug":"nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a","status":"publish","type":"post","link":"https:\/\/nexxus-iberia.es\/en\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/","title":{"rendered":"Nexxus Iberia sells Bienzobas Oncolog\u00eda to Atrys Health, S.A."},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"13543\" class=\"elementor elementor-13543\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b42a030 e-con-full e-flex parallax_section_no qode_elementor_container_no e-con e-parent\" data-id=\"b42a030\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b9bdbac elementor-widget elementor-widget-post-info\" data-id=\"b9bdbac\" data-element_type=\"widget\" data-widget_type=\"post-info.default\">\n\t\t\t\t\t\t\t<ul class=\"elementor-inline-items elementor-icon-list-items elementor-post-info\">\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item elementor-repeater-item-8231886 elementor-inline-item\" itemprop=\"datePublished\">\n\t\t\t\t\t\t<a href=\"https:\/\/nexxus-iberia.es\/en\/2022\/06\/13\/\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-calendar\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M12 192h424c6.6 0 12 5.4 12 12v260c0 26.5-21.5 48-48 48H48c-26.5 0-48-21.5-48-48V204c0-6.6 5.4-12 12-12zm436-44v-36c0-26.5-21.5-48-48-48h-48V12c0-6.6-5.4-12-12-12h-40c-6.6 0-12 5.4-12 12v52H160V12c0-6.6-5.4-12-12-12h-40c-6.6 0-12 5.4-12 12v52H48C21.5 64 0 85.5 0 112v36c0 6.6 5.4 12 12 12h424c6.6 0 12-5.4 12-12z\"><\/path><\/svg>\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text elementor-post-info__item elementor-post-info__item--type-date\">\n\t\t\t\t\t\t\t\t\t\t<time>06\/13\/2022<\/time>\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t<\/li>\n\t\t\t\t<li class=\"elementor-icon-list-item elementor-repeater-item-584c50e elementor-inline-item\">\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-far-clock\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8zm0 448c-110.5 0-200-89.5-200-200S145.5 56 256 56s200 89.5 200 200-89.5 200-200 200zm61.8-104.4l-84.9-61.7c-3.1-2.3-4.9-5.9-4.9-9.7V116c0-6.6 5.4-12 12-12h32c6.6 0 12 5.4 12 12v141.7l66.8 48.6c5.4 3.9 6.5 11.4 2.6 16.8L334.6 349c-3.9 5.3-11.4 6.5-16.8 2.6z\"><\/path><\/svg>\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text elementor-post-info__item elementor-post-info__item--type-time\">\n\t\t\t\t\t\t\t\t\t\t<time>3:05 am<\/time>\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-58747ef e-con-full e-flex parallax_section_no qode_elementor_container_no e-con e-parent\" data-id=\"58747ef\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-43b8dc5 elementor-widget elementor-widget-text-editor\" data-id=\"43b8dc5\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Founded in 2000 by Eliseo and Paula Garc\u00eda, Bienzobas is the Spanish leader in the provision and management of medical oncology services with a growing international presence in Mexico and Portugal. Bienzobas is currently responsible for the oncology treatment of a reference population of more than 2 million insured patients. It is also the leader in oncology consulting services in Spain, through agreements with the main health insurance companies and healthcare groups in the country. Bienzobas has a network of more than 70 oncologists in Spain, is present in more than 40 hospitals and medical centers and treats more than 2,000 patients annually.<br>In February 2020, funds managed by Nexxus Iberia took a controlling stake in Bienzobas to support the company in its growth, its professionalization and internationalization with the view of building strategic value.<br>With the active support of its shareholders and under the management of Marian Isach, a Nexxus-backed CEO, Bienzobas has grown consistently in recent years, reaching above \u20ac31M in revenue in 2021.<\/p>\n<p>In two and half years of Nexxus\u2019 ownership, the workforce has grown by 64% and Bienzobas has expanded to Mexico through the acquisition of Cuidarte. Bienzobas has also developed its own technological platform that uses big data and artificial intelligence to optimize healthcare management, support clinical decisions and enhance patient monitoring. It has also focused on improving patient\u00b4s experience and quality of care with initiatives such as post treatment follow-up, quality surveys throughout the patient journey, and constant review of protocols and circuits, in accordance with best practices (obtaining ISO 9001 as a result).<br>Eliseo and Paula Garc\u00eda, Bienzobas\u2019 founders commented: As founders of Bienzobas, maintaining our medical model was paramount to us, our patients and the team that had worked with us for the last twenty years. The choice of Nexxus Iberia was driven by our belief that they would be a collaborative partner that would help us further improve our service to patients whilst growing in Spain and Internationally. Nexxus Iberia trusted us in our way of managing our clinical practice and people and they have been of great help in achieving growth whilst improving quality. Our people have had many opportunities to develop and grow professionally throughout this journey.<\/p>\n<p>Marian Isach, CEO of Bienzobas Oncolog\u00eda further commented: Partnering with Nexxus Iberia gave us the flexibility to develop our shared plan for national and international growth. Their ability<br>to adapt to a family business like Bienzobas has given us the opportunity to consolidate the project and introduce new resources, which have made it possible. However, the greatest contribution of Nexxus Iberia to our company has been the honesty, flexibility and, above all, humanity with which they have accompanied us during these two intense years, as true traveling companions.<\/p>\n<p>Alejandro Diazayas, Managing Partner of Nexxus Iberia further commented: \u201cWe are proud of having contributed to the value creation of Bienzobas in conjunction with our partners, the executive management team and all the employees. At Nexxus Iberia we have built over the years expertise in healthcare as a suitable sector for our investment strategy and also a sector which is in adequation with our broader values of serving a purpose. Indeed, with Bienzobas we were really proud to support a company that cares for people and constantly looks to improve patients\u2019 lives and livelihoods.\u201d<br>Maite Ballester, Managing Partner of Nexxus Iberia further commented: \u201cBienzobas is a great example of a success story backed by Nexxus Iberia and reflects our investment strategy in family run companies to support them in the acceleration of growth and the international expansion. We would like to congratulate founders Eliseo and Paula Garc\u00eda as well as Marian Isach for what they have accomplished with us. We are convinced that Atrys, a global healthcare group is testament to the strategic value created under our ownership with founders and management and we are convinced that Atrys is very well-positioned to support Bienzobas in the next phase of its growth.<br>EY acted as legal advisor to the sellers in the transaction.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-57f476c e-con-full e-flex parallax_section_no qode_elementor_container_no e-con e-parent\" data-id=\"57f476c\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a24f938 elementor-widget elementor-widget-text-editor\" data-id=\"a24f938\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><\/p>\n<p><a href=\"https:\/\/bienzobas.es\/\" target=\"_blank\" rel=\"noopener\">Https:\/\/aerocamaras.es\/<\/a><\/p>\n<div class=\"entry-content\">\n<p><a href=\"https:\/\/nexxus-iberia.es\/wp-content\/uploads\/2025\/08\/220613-Bienzobas-Press-Realse.pdf\">LEER NOTICIA COMPLETA AQU\u00cd<\/a>&nbsp;<\/p>\n<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Founded in 2000 by Eliseo and Paula Garc\u00eda, Bienzobas is the Spanish leader in the provision and management of medical oncology services with a growing international presence in Mexico and Portugal. Bienzobas is currently responsible for the oncology treatment of a reference population of more&#8230;<\/p>","protected":false},"author":2,"featured_media":13545,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-13543","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categoria"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Nexxus Iberia sells Bienzobas Oncolog\u00eda to Atrys Health, S.A. - Nexxus Iberia<\/title>\n<meta name=\"description\" content=\"Nexxus Iberia sells Bienzobas Oncolog\u00eda to Atrys Health, S.A.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nexxus-iberia.es\/en\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nexxus Iberia sells Bienzobas Oncolog\u00eda to Atrys Health, S.A. - Nexxus Iberia\" \/>\n<meta property=\"og:description\" content=\"Nexxus Iberia sells Bienzobas Oncolog\u00eda to Atrys Health, S.A.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nexxus-iberia.es\/en\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/\" \/>\n<meta property=\"og:site_name\" content=\"Nexxus Iberia\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-13T01:05:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-11T15:24:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nexxus-iberia.es\/wp-content\/uploads\/2025\/08\/Nexxus-Iberia-sells-Bienzobas-Oncologia-to-Atrys-Health-S.A.png\" \/>\n\t<meta property=\"og:image:width\" content=\"718\" \/>\n\t<meta property=\"og:image:height\" content=\"371\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Admin2\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Admin2\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/\"},\"author\":{\"name\":\"Admin2\",\"@id\":\"https:\/\/nexxus-iberia.es\/#\/schema\/person\/1015bfce8c439424c156311ab4c1adc5\"},\"headline\":\"Nexxus Iberia sells Bienzobas Oncolog\u00eda to Atrys Health, S.A.\",\"datePublished\":\"2022-06-13T01:05:19+00:00\",\"dateModified\":\"2025-12-11T15:24:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/\"},\"wordCount\":682,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/nexxus-iberia.es\/#organization\"},\"image\":{\"@id\":\"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/nexxus-iberia.es\/wp-content\/uploads\/2025\/08\/Nexxus-Iberia-sells-Bienzobas-Oncologia-to-Atrys-Health-S.A.png\",\"articleSection\":[\"Sin categor\u00eda\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/\",\"url\":\"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/\",\"name\":\"Nexxus Iberia sells Bienzobas Oncolog\u00eda to Atrys Health, S.A. - Nexxus Iberia\",\"isPartOf\":{\"@id\":\"https:\/\/nexxus-iberia.es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/nexxus-iberia.es\/wp-content\/uploads\/2025\/08\/Nexxus-Iberia-sells-Bienzobas-Oncologia-to-Atrys-Health-S.A.png\",\"datePublished\":\"2022-06-13T01:05:19+00:00\",\"dateModified\":\"2025-12-11T15:24:40+00:00\",\"description\":\"Nexxus Iberia sells Bienzobas Oncolog\u00eda to Atrys Health, S.A.\",\"breadcrumb\":{\"@id\":\"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/#primaryimage\",\"url\":\"https:\/\/nexxus-iberia.es\/wp-content\/uploads\/2025\/08\/Nexxus-Iberia-sells-Bienzobas-Oncologia-to-Atrys-Health-S.A.png\",\"contentUrl\":\"https:\/\/nexxus-iberia.es\/wp-content\/uploads\/2025\/08\/Nexxus-Iberia-sells-Bienzobas-Oncologia-to-Atrys-Health-S.A.png\",\"width\":718,\"height\":371},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/nexxus-iberia.es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nexxus Iberia sells Bienzobas Oncolog\u00eda to Atrys Health, S.A.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/nexxus-iberia.es\/#website\",\"url\":\"https:\/\/nexxus-iberia.es\/\",\"name\":\"Nexxus Iberia\",\"description\":\"Nexxus Iberia Fund I impulsa pymes en Espa\u00f1a con capital flexible (10\u201325 M\u20ac), priorizando eficiencia, expansi\u00f3n a Europa y LatAm, talento directivo, adquisiciones y digitalizaci\u00f3n para crear valor sostenible.\",\"publisher\":{\"@id\":\"https:\/\/nexxus-iberia.es\/#organization\"},\"alternateName\":\"Nexxus Iberia\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/nexxus-iberia.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/nexxus-iberia.es\/#organization\",\"name\":\"Nexxus Iberia\",\"url\":\"https:\/\/nexxus-iberia.es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/nexxus-iberia.es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/nexxus-iberia.es\/wp-content\/uploads\/2025\/07\/logo-azul-negro.png\",\"contentUrl\":\"https:\/\/nexxus-iberia.es\/wp-content\/uploads\/2025\/07\/logo-azul-negro.png\",\"width\":200,\"height\":62,\"caption\":\"Nexxus Iberia\"},\"image\":{\"@id\":\"https:\/\/nexxus-iberia.es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/nexxus-iberia\/about\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/nexxus-iberia.es\/#\/schema\/person\/1015bfce8c439424c156311ab4c1adc5\",\"name\":\"Admin2\",\"url\":\"https:\/\/nexxus-iberia.es\/en\/author\/admin2\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nexxus Iberia sells Bienzobas Oncolog\u00eda to Atrys Health, S.A. - Nexxus Iberia","description":"Nexxus Iberia sells Bienzobas Oncolog\u00eda to Atrys Health, S.A.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nexxus-iberia.es\/en\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/","og_locale":"en_US","og_type":"article","og_title":"Nexxus Iberia sells Bienzobas Oncolog\u00eda to Atrys Health, S.A. - Nexxus Iberia","og_description":"Nexxus Iberia sells Bienzobas Oncolog\u00eda to Atrys Health, S.A.","og_url":"https:\/\/nexxus-iberia.es\/en\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/","og_site_name":"Nexxus Iberia","article_published_time":"2022-06-13T01:05:19+00:00","article_modified_time":"2025-12-11T15:24:40+00:00","og_image":[{"width":718,"height":371,"url":"https:\/\/nexxus-iberia.es\/wp-content\/uploads\/2025\/08\/Nexxus-Iberia-sells-Bienzobas-Oncologia-to-Atrys-Health-S.A.png","type":"image\/png"}],"author":"Admin2","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Admin2","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/#article","isPartOf":{"@id":"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/"},"author":{"name":"Admin2","@id":"https:\/\/nexxus-iberia.es\/#\/schema\/person\/1015bfce8c439424c156311ab4c1adc5"},"headline":"Nexxus Iberia sells Bienzobas Oncolog\u00eda to Atrys Health, S.A.","datePublished":"2022-06-13T01:05:19+00:00","dateModified":"2025-12-11T15:24:40+00:00","mainEntityOfPage":{"@id":"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/"},"wordCount":682,"commentCount":0,"publisher":{"@id":"https:\/\/nexxus-iberia.es\/#organization"},"image":{"@id":"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/#primaryimage"},"thumbnailUrl":"https:\/\/nexxus-iberia.es\/wp-content\/uploads\/2025\/08\/Nexxus-Iberia-sells-Bienzobas-Oncologia-to-Atrys-Health-S.A.png","articleSection":["Sin categor\u00eda"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/","url":"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/","name":"Nexxus Iberia sells Bienzobas Oncolog\u00eda to Atrys Health, S.A. - Nexxus Iberia","isPartOf":{"@id":"https:\/\/nexxus-iberia.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/#primaryimage"},"image":{"@id":"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/#primaryimage"},"thumbnailUrl":"https:\/\/nexxus-iberia.es\/wp-content\/uploads\/2025\/08\/Nexxus-Iberia-sells-Bienzobas-Oncologia-to-Atrys-Health-S.A.png","datePublished":"2022-06-13T01:05:19+00:00","dateModified":"2025-12-11T15:24:40+00:00","description":"Nexxus Iberia sells Bienzobas Oncolog\u00eda to Atrys Health, S.A.","breadcrumb":{"@id":"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/#primaryimage","url":"https:\/\/nexxus-iberia.es\/wp-content\/uploads\/2025\/08\/Nexxus-Iberia-sells-Bienzobas-Oncologia-to-Atrys-Health-S.A.png","contentUrl":"https:\/\/nexxus-iberia.es\/wp-content\/uploads\/2025\/08\/Nexxus-Iberia-sells-Bienzobas-Oncologia-to-Atrys-Health-S.A.png","width":718,"height":371},{"@type":"BreadcrumbList","@id":"https:\/\/nexxus-iberia.es\/nexxus-iberia-sells-bienzobas-oncologia-to-atrys-health-s-a\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/nexxus-iberia.es\/"},{"@type":"ListItem","position":2,"name":"Nexxus Iberia sells Bienzobas Oncolog\u00eda to Atrys Health, S.A."}]},{"@type":"WebSite","@id":"https:\/\/nexxus-iberia.es\/#website","url":"https:\/\/nexxus-iberia.es\/","name":"Nexxus Iberia","description":"Nexxus Iberia Fund I impulsa pymes en Espa\u00f1a con capital flexible (10\u201325 M\u20ac), priorizando eficiencia, expansi\u00f3n a Europa y LatAm, talento directivo, adquisiciones y digitalizaci\u00f3n para crear valor sostenible.","publisher":{"@id":"https:\/\/nexxus-iberia.es\/#organization"},"alternateName":"Nexxus Iberia","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nexxus-iberia.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/nexxus-iberia.es\/#organization","name":"Nexxus Iberia","url":"https:\/\/nexxus-iberia.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nexxus-iberia.es\/#\/schema\/logo\/image\/","url":"https:\/\/nexxus-iberia.es\/wp-content\/uploads\/2025\/07\/logo-azul-negro.png","contentUrl":"https:\/\/nexxus-iberia.es\/wp-content\/uploads\/2025\/07\/logo-azul-negro.png","width":200,"height":62,"caption":"Nexxus Iberia"},"image":{"@id":"https:\/\/nexxus-iberia.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/nexxus-iberia\/about\/"]},{"@type":"Person","@id":"https:\/\/nexxus-iberia.es\/#\/schema\/person\/1015bfce8c439424c156311ab4c1adc5","name":"Admin2","url":"https:\/\/nexxus-iberia.es\/en\/author\/admin2\/"}]}},"_links":{"self":[{"href":"https:\/\/nexxus-iberia.es\/en\/wp-json\/wp\/v2\/posts\/13543","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nexxus-iberia.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nexxus-iberia.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nexxus-iberia.es\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nexxus-iberia.es\/en\/wp-json\/wp\/v2\/comments?post=13543"}],"version-history":[{"count":11,"href":"https:\/\/nexxus-iberia.es\/en\/wp-json\/wp\/v2\/posts\/13543\/revisions"}],"predecessor-version":[{"id":15093,"href":"https:\/\/nexxus-iberia.es\/en\/wp-json\/wp\/v2\/posts\/13543\/revisions\/15093"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nexxus-iberia.es\/en\/wp-json\/wp\/v2\/media\/13545"}],"wp:attachment":[{"href":"https:\/\/nexxus-iberia.es\/en\/wp-json\/wp\/v2\/media?parent=13543"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nexxus-iberia.es\/en\/wp-json\/wp\/v2\/categories?post=13543"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nexxus-iberia.es\/en\/wp-json\/wp\/v2\/tags?post=13543"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}